Published in Dermatol Surg on January 01, 2006
Where is it? The utility of biopsy-site photography. Dermatol Surg (2009) 0.82
BIOPSY 1-2-3 in Dermatologic Surgery: Improving Smartphone use to Avoid Wrong-Site Surgery. Technol Innov (2016) 0.75
The value of preoperative biopsy-site photography for identifying cutaneous lesions. Dermatol Surg (2009) 0.75
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 7.94
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Retraction of an interpretation. Lancet (2004) 3.55
Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med (2009) 2.72
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2009) 2.39
Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry (2010) 2.06
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry (2009) 1.96
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry (2006) 1.93
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry (2007) 1.88
Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry (2010) 1.82
Validation of electronic health record phenotyping of bipolar disorder cases and controls. Am J Psychiatry (2014) 1.79
Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. Am J Psychiatry (2012) 1.57
A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. J Clin Psychopharmacol (2006) 1.57
Assuring that double-blind is blind. Am J Psychiatry (2010) 1.56
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. J Clin Psychiatry (2013) 1.53
Post-Mohs micrographic surgical margin tissue evaluation with permanent histopathologic sections. Dermatol Surg (2005) 1.48
QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ (2013) 1.40
Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task. Biol Psychiatry (2008) 1.38
Repair of lateral sidewall and partial alar defects: nasalis island pedicle flap with partial second-intention healing. Dermatol Surg (2011) 1.37
Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry (2009) 1.33
Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. PLoS One (2010) 1.29
L-type calcium channels and psychiatric disorders: A brief review. Am J Med Genet B Neuropsychiatr Genet (2010) 1.28
Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord (2006) 1.28
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse? Neuron (2008) 1.27
Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder. Psychopharmacol Bull (2007) 1.19
Characteristics of Mohs practices in the United States: a recall survey of ACMS surgeons. Dermatol Surg (2007) 1.15
Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. BMJ Open (2012) 1.13
Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. Nat Genet (2007) 1.11
Corticotropin-releasing hormone receptor type 1 (CRHR1) genetic variation and stress interact to influence reward learning. J Neurosci (2011) 1.10
Personality disorders and perceived stress in major depressive disorder. Psychiatry Res (2008) 1.09
Extent and impact of industry sponsorship conflicts of interest in dermatology research. J Am Acad Dermatol (2005) 1.09
Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry (2006) 1.08
Adenoma of anogenital mammary-like glands. J Am Acad Dermatol (2007) 1.06
Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV. Depress Anxiety (2013) 1.05
Association of a brain methylation site with clinical outcomes in depression does not replicate across populations. Am J Psychiatry (2015) 1.05
Pharmacogenetics studies in STAR*D: strengths, limitations, and results. Psychiatr Serv (2009) 1.04
Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment. Psychosomatics (2004) 1.03
First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. J Clin Psychiatry (2013) 1.02
Dermatologic conditions seen in end-stage renal disease. Semin Dial (2009) 0.99
Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol Psychiatry (2005) 0.99
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Self-report and clinician-rated measures of depression severity: can one replace the other? Depress Anxiety (2012) 0.98
Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disord (2009) 0.97
A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder. J Occup Environ Med (2008) 0.97
Modifiers and subtype-specific analyses in whole-genome association studies: a likelihood framework. Hum Hered (2011) 0.96
Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 0.96
Recurrent, robust and scalable patterns underlie human approach and avoidance. PLoS One (2010) 0.96
Presence of irritability during depressive episodes in bipolar disorder. CNS Spectr (2004) 0.94
Biomarkers predicting treatment outcome in depression: what is clinically significant? Pharmacogenomics (2012) 0.93
Tanning in body dysmorphic disorder. Psychiatr Q (2006) 0.92
Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association. Bipolar Disord (2013) 0.92
Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data. World J Biol Psychiatry (2012) 0.90
Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans. Hum Brain Mapp (2010) 0.89
Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin). J Invest Dermatol (2005) 0.89
Sleep disturbance in euthymic bipolar patients. J Psychopharmacol (2011) 0.88
Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record: a pilot study. Psychiatry Res (2012) 0.88
Hard outcomes: clinical trials to reduce suicide. Am J Psychiatry (2011) 0.88
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS One (2013) 0.88
Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis. Am J Gastroenterol (2013) 0.87
Orf acquired during religious observance. Arch Dermatol (2009) 0.86
Weight gain during treatment of bipolar I patients with olanzapine. J Clin Psychiatry (2004) 0.85
Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2013) 0.84
The use of mole-mapping diagrams to increase skin self-examination accuracy. J Am Acad Dermatol (2006) 0.84
The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry. J Clin Psychiatry (2006) 0.83
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications. J Clin Psychiatry (2007) 0.83
Course, outcomes, and psychosocial interventions for first-episode mania. Bipolar Disord (2012) 0.83
A clinical perspective on the relevance of research domain criteria in electronic health records. Am J Psychiatry (2015) 0.82
A critical review of pharmacotherapy for major depressive disorder. Int J Neuropsychopharmacol (2011) 0.82
An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. J Clin Psychiatry (2005) 0.82
Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder. J Clin Psychopharmacol (2013) 0.82
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels. Eur Neuropsychopharmacol (2012) 0.82
A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery. Dermatol Surg (2007) 0.82
Clinical relevance of depressive symptom improvement in bipolar I depressed patients. J Affect Disord (2006) 0.82
Meningiomas after medulloblastoma irradiation treatment in a patient with basal cell nevus syndrome. J Am Acad Dermatol (2005) 0.81
Cytochrome P450 genotyping and antidepressants. BMJ (2007) 0.81
Body dysmorphic disorder and cosmetic dermatology: more than skin deep. J Cosmet Dermatol (2004) 0.81
Pharmacogenomic strategy for individualizing antidepressant therapy. Dialogues Clin Neurosci (2008) 0.81
Bipolar polygenic loading and bipolar spectrum features in major depressive disorder. Bipolar Disord (2014) 0.80
A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. J Clin Psychiatry (2006) 0.80
Dietary supplements in the setting of mohs surgery. Dermatol Surg (2002) 0.80
Double purse-string closure for scalp and extremity wounds. Dermatol Surg (2007) 0.80
Risks for the transition from major depressive disorder to bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2012) 0.80
Low-dose transdermal testosterone augmentation therapy improves depression severity in women. CNS Spectr (2009) 0.80
The association of single nucleotide polymorphisms in the catechol-O-methyltransferase gene and pain scores in female patients with major depressive disorder. J Pain (2010) 0.79
Safety of cosmetic dermatologic procedures during pregnancy. Dermatol Surg (2013) 0.79
Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial. Psychopharmacol Bull (2008) 0.78
Treatment of squamous cell carcinoma in situ: a review. Dermatol Surg (2011) 0.78
Bipolar disorder and a history of suicide attempts with a duplication in 5HTR1A. Am J Psychiatry (2012) 0.78
Reduced pain with use of proprietary hyaluronic acid with lidocaine for correction of nasolabial folds: a patient-blinded, prospective, randomized controlled trial. Dermatol Surg (2009) 0.78
Pharmacogenetics, race, and psychiatry: prospects and challenges. Harv Rev Psychiatry (2006) 0.78
Multiple antithrombotic agents increase the risk of postoperative hemorrhage in dermatologic surgery. J Am Acad Dermatol (2008) 0.77
Betting on biomarkers. Am J Psychiatry (2011) 0.77
An alternative approach to reconstruction of the lateral nose. Dermatol Surg (2013) 0.76
Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis. J Clin Psychiatry (2012) 0.76
Antidepressant dose reduction and the risk of relapse in major depressive disorder. Psychother Psychosom (2007) 0.76
Treatment of bipolar depression. CNS Spectr (2003) 0.76